Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roche patents V1a receptor antagonists

Sep. 8, 2015

Novita Pharmaceuticals and Cornell University report fascin inhibitors

Sep. 8, 2015

Bristol-Myers Squibb introduces new HIV integrase inhibitors

Sep. 8, 2015

Piramal discloses GPR120 agonists

Sep. 8, 2015

Bristol-Myers Squibb introduces HIV integrase inhibitors

Sep. 7, 2015

Achillion discovers complement factor D inhibitors

Sep. 7, 2015

Boehringer Ingelheim discloses neutrophil elastase inhibitors

Sep. 7, 2015

Bionomics presents new VEGFR-3/FAK inhibitors

Sep. 7, 2015

Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors

Sep. 7, 2015

Frost Biologic discloses new antimitotics

Sep. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...